25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Sorrento Therape
Buy, Hold or Sell?

Let's analyze Sorrento Therape together

I guess you are interested in Sorrento Therape. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sorrento Therape. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sorrento Therape

I send you an email if I find something interesting about Sorrento Therape.

1. Quick Overview

1.1. Quick analysis of Sorrento Therape (30 sec.)










1.2. What can you expect buying and holding a share of Sorrento Therape? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.04
Expected worth in 1 year
$-0.76
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$-0.72
Return On Investment
-19,570.7%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0006 - $0.01
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sorrento Therape (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-6.29 - $-4.61
Total Value Per Share
$-6.33 - $-4.65

2.2. Growth of Sorrento Therape (5 min.)




Is Sorrento Therape growing?

Current yearPrevious yearGrowGrow %
How rich?-$21.6m$78.1m-$99.7m-460.6%

How much money is Sorrento Therape making?

Current yearPrevious yearGrowGrow %
Making money-$559.3m-$429m-$130.3m-23.3%
Net Profit Margin-890.1%-810.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Sorrento Therape (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#914 / 959

Most Revenue
#115 / 959

Most Profit
#956 / 959

Most Efficient
#700 / 959
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sorrento Therape?

Welcome investor! Sorrento Therape's management wants to use your money to grow the business. In return you get a share of Sorrento Therape.

First you should know what it really means to hold a share of Sorrento Therape. And how you can make/lose money.

Speculation

The Price per Share of Sorrento Therape is $0.0037. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sorrento Therape.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sorrento Therape, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.04. Based on the TTM, the Book Value Change Per Share is $-0.18 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sorrento Therape.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.04-28,084.1%-1.04-28,084.1%-0.78-20,999.0%-0.65-17,602.6%-0.35-9,557.1%
Usd Book Value Change Per Share-0.18-4,892.7%-0.18-4,892.7%-0.11-3,069.1%-0.08-2,238.3%-0.01-136.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.18-4,892.7%-0.18-4,892.7%-0.11-3,069.1%-0.08-2,238.3%-0.01-136.6%
Usd Price Per Share0.89-0.89-4.65-3.63-5.37-
Price to Earnings Ratio-0.85--0.85--5.98--6.46--31.61-
Price-to-Total Gains Ratio-4.89--4.89--40.95-292.99-178.79-
Price to Book Ratio-22.54--22.54-32.81-20.05-29.36-
Price-to-Total Gains Ratio-4.89--4.89--40.95-292.99-178.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0037
Number of shares270270
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.18-0.08
Usd Total Gains Per Share-0.18-0.08
Gains per Quarter (270270 shares)-48,926.78-22,383.13
Gains per Year (270270 shares)-195,707.12-89,532.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-195707-1957170-89533-89543
20-391414-3914240-179065-179076
30-587121-5871310-268598-268609
40-782828-7828380-358130-358142
50-978536-9785450-447663-447675
60-1174243-11742520-537195-537208
70-1369950-13699590-626728-626741
80-1565657-15656660-716260-716274
90-1761364-17613730-805793-805807
100-1957071-19570800-895325-895340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%1.015.00.06.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%11.05.00.068.8%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.016.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%11.05.00.068.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sorrento Therape compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.181-0.1810%-0.114-37%-0.083-54%-0.005-97%
Book Value Per Share---0.039-0.0390%0.142-128%0.159-125%0.190-121%
Current Ratio--0.2940.2940%1.240-76%1.186-75%2.574-89%
Debt To Asset Ratio--1.0461.0460%0.888+18%0.856+22%0.669+56%
Debt To Equity Ratio----0%7.831-100%3.778-100%2.604-100%
Dividend Per Share----0%-0%-0%-0%
Eps---1.039-1.0390%-0.777-25%-0.651-37%-0.354-66%
Free Cash Flow Per Share---0.558-0.5580%-0.527-5%-0.400-28%-0.251-55%
Free Cash Flow To Equity Per Share--0.0080.0080%-0.198+2701%-0.011+245%-0.001+114%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.606--------
Intrinsic Value_10Y_min---6.290--------
Intrinsic Value_1Y_max---0.297--------
Intrinsic Value_1Y_min---0.524--------
Intrinsic Value_3Y_max---1.018--------
Intrinsic Value_3Y_min---1.676--------
Intrinsic Value_5Y_max---1.890--------
Intrinsic Value_5Y_min---2.930--------
Market Cap2039739.789-23846%488434987.264488434987.2640%2563456761.600-81%2000157811.277-76%2961536789.030-84%
Net Profit Margin---8.901-8.9010%-8.109-9%-9.151+3%-11.983+35%
Operating Margin---6.079-6.0790%-7.557+24%-6.457+6%-9.767+61%
Operating Ratio--7.0237.0230%7.957-12%7.068-1%10.135-31%
Pb Ratio-0.094+100%-22.541-22.5410%32.811-169%20.053-212%29.361-177%
Pe Ratio-0.004+100%-0.853-0.8530%-5.985+602%-6.465+658%-31.605+3607%
Price Per Share0.004-23846%0.8860.8860%4.650-81%3.628-76%5.372-84%
Price To Free Cash Flow Ratio-0.007+100%-1.588-1.5880%-8.818+455%-10.071+534%-65.445+4020%
Price To Total Gains Ratio-0.020+100%-4.894-4.8940%-40.948+737%292.988-102%178.791-103%
Quick Ratio--0.3070.3070%1.691-82%1.676-82%3.096-90%
Return On Assets---1.183-1.1830%-0.617-48%-0.669-43%-0.409-65%
Return On Equity----0%-5.4480%-2.5710%-1.4540%
Total Gains Per Share---0.181-0.1810%-0.114-37%-0.083-54%-0.005-97%
Usd Book Value---21669000.000-21669000.0000%78129000.000-128%87489400.000-125%104701913.100-121%
Usd Book Value Change Per Share---0.181-0.1810%-0.114-37%-0.083-54%-0.005-97%
Usd Book Value Per Share---0.039-0.0390%0.142-128%0.159-125%0.190-121%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.039-1.0390%-0.777-25%-0.651-37%-0.354-66%
Usd Free Cash Flow---307514000.000-307514000.0000%-290692000.000-5%-220544200.000-28%-138317691.200-55%
Usd Free Cash Flow Per Share---0.558-0.5580%-0.527-5%-0.400-28%-0.251-55%
Usd Free Cash Flow To Equity Per Share--0.0080.0080%-0.198+2701%-0.011+245%-0.001+114%
Usd Market Cap2039739.789-23846%488434987.264488434987.2640%2563456761.600-81%2000157811.277-76%2961536789.030-84%
Usd Price Per Share0.004-23846%0.8860.8860%4.650-81%3.628-76%5.372-84%
Usd Profit---559331000.000-559331000.0000%-429012000.000-23%-371910400.000-34%-201372226.300-64%
Usd Revenue--62839000.00062839000.0000%52904000.000+19%41670800.000+51%37723714.800+67%
Usd Total Gains Per Share---0.181-0.1810%-0.114-37%-0.083-54%-0.005-97%
 EOD+2 -6MRQTTM+0 -0YOY+9 -235Y+9 -2310Y+9 -23

3.3 Fundamental Score

Let's check the fundamental score of Sorrento Therape based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.004
Price to Book Ratio (EOD)Between0-1-0.094
Net Profit Margin (MRQ)Greater than0-8.901
Operating Margin (MRQ)Greater than0-6.079
Quick Ratio (MRQ)Greater than10.307
Current Ratio (MRQ)Greater than10.294
Debt to Asset Ratio (MRQ)Less than11.046
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.183
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Sorrento Therape based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.939
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.007
OpenGreater thanClose0.003
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Sorrento Therape

Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,and pain. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis pain treatment; and ZTlido, a lidocaine topical system for the treatment of post-herpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California. On February 13, 2023, Sorrento Therapeutics, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas. The plan was later approved as C

Fundamental data was last updated by Penke on 2024-11-10 00:12:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sorrento Therape earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sorrento Therape to the Biotechnology industry mean.
  • A Net Profit Margin of -890.1% means that $-8.90 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sorrento Therape:

  • The MRQ is -890.1%. The company is making a huge loss. -2
  • The TTM is -890.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-890.1%TTM-890.1%0.0%
TTM-890.1%YOY-810.9%-79.2%
TTM-890.1%5Y-915.1%+25.0%
5Y-915.1%10Y-1,198.3%+283.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-890.1%-132.1%-758.0%
TTM-890.1%-204.9%-685.2%
YOY-810.9%-207.4%-603.5%
5Y-915.1%-353.5%-561.6%
10Y-1,198.3%-466.1%-732.2%
4.3.1.2. Return on Assets

Shows how efficient Sorrento Therape is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sorrento Therape to the Biotechnology industry mean.
  • -118.3% Return on Assets means that Sorrento Therape generated $-1.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sorrento Therape:

  • The MRQ is -118.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -118.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-118.3%TTM-118.3%0.0%
TTM-118.3%YOY-61.7%-56.5%
TTM-118.3%5Y-66.9%-51.4%
5Y-66.9%10Y-40.9%-26.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-118.3%-10.8%-107.5%
TTM-118.3%-11.8%-106.5%
YOY-61.7%-11.0%-50.7%
5Y-66.9%-12.6%-54.3%
10Y-40.9%-14.4%-26.5%
4.3.1.3. Return on Equity

Shows how efficient Sorrento Therape is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sorrento Therape to the Biotechnology industry mean.
  • 0.0% Return on Equity means Sorrento Therape generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sorrento Therape:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-544.8%+544.8%
TTM-5Y-257.1%+257.1%
5Y-257.1%10Y-145.4%-111.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.6%+13.6%
TTM--15.9%+15.9%
YOY-544.8%-13.5%-531.3%
5Y-257.1%-18.6%-238.5%
10Y-145.4%-19.0%-126.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sorrento Therape.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sorrento Therape is operating .

  • Measures how much profit Sorrento Therape makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sorrento Therape to the Biotechnology industry mean.
  • An Operating Margin of -607.9% means the company generated $-6.08  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sorrento Therape:

  • The MRQ is -607.9%. The company is operating very inefficient. -2
  • The TTM is -607.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-607.9%TTM-607.9%0.0%
TTM-607.9%YOY-755.7%+147.8%
TTM-607.9%5Y-645.7%+37.8%
5Y-645.7%10Y-976.7%+331.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-607.9%-271.8%-336.1%
TTM-607.9%-312.9%-295.0%
YOY-755.7%-222.0%-533.7%
5Y-645.7%-385.5%-260.2%
10Y-976.7%-495.6%-481.1%
4.3.2.2. Operating Ratio

Measures how efficient Sorrento Therape is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 7.02 means that the operating costs are $7.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sorrento Therape:

  • The MRQ is 7.023. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.023. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ7.023TTM7.0230.000
TTM7.023YOY7.957-0.934
TTM7.0235Y7.068-0.044
5Y7.06810Y10.135-3.067
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0232.825+4.198
TTM7.0233.198+3.825
YOY7.9573.301+4.656
5Y7.0684.800+2.268
10Y10.1356.530+3.605
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sorrento Therape.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sorrento Therape is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.29 means the company has $0.29 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sorrento Therape:

  • The MRQ is 0.294. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.294. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.294TTM0.2940.000
TTM0.294YOY1.240-0.947
TTM0.2945Y1.186-0.892
5Y1.18610Y2.574-1.388
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2943.765-3.471
TTM0.2943.923-3.629
YOY1.2404.708-3.468
5Y1.1865.959-4.773
10Y2.5746.278-3.704
4.4.3.2. Quick Ratio

Measures if Sorrento Therape is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sorrento Therape to the Biotechnology industry mean.
  • A Quick Ratio of 0.31 means the company can pay off $0.31 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sorrento Therape:

  • The MRQ is 0.307. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.307. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.307TTM0.3070.000
TTM0.307YOY1.691-1.384
TTM0.3075Y1.676-1.369
5Y1.67610Y3.096-1.420
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3073.346-3.039
TTM0.3073.502-3.195
YOY1.6914.682-2.991
5Y1.6765.922-4.246
10Y3.0966.458-3.362
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sorrento Therape.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sorrento Therape assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sorrento Therape to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.05 means that Sorrento Therape assets are financed with 104.6% credit (debt) and the remaining percentage (100% - 104.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sorrento Therape:

  • The MRQ is 1.046. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.046. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.046TTM1.0460.000
TTM1.046YOY0.888+0.158
TTM1.0465Y0.856+0.190
5Y0.85610Y0.669+0.187
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0460.338+0.708
TTM1.0460.347+0.699
YOY0.8880.310+0.578
5Y0.8560.365+0.491
10Y0.6690.381+0.288
4.5.4.2. Debt to Equity Ratio

Measures if Sorrento Therape is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sorrento Therape to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sorrento Therape:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY7.831-7.831
TTM-5Y3.778-3.778
5Y3.77810Y2.604+1.174
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.387-0.387
TTM-0.437-0.437
YOY7.8310.376+7.455
5Y3.7780.450+3.328
10Y2.6040.489+2.115
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sorrento Therape generates.

  • Above 15 is considered overpriced but always compare Sorrento Therape to the Biotechnology industry mean.
  • A PE ratio of -0.85 means the investor is paying $-0.85 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sorrento Therape:

  • The EOD is -0.004. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.853. Based on the earnings, the company is expensive. -2
  • The TTM is -0.853. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.004MRQ-0.853+0.849
MRQ-0.853TTM-0.8530.000
TTM-0.853YOY-5.985+5.132
TTM-0.8535Y-6.465+5.612
5Y-6.46510Y-31.605+25.141
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.004-2.320+2.316
MRQ-0.853-2.435+1.582
TTM-0.853-2.977+2.124
YOY-5.985-3.444-2.541
5Y-6.465-5.970-0.495
10Y-31.605-6.467-25.138
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sorrento Therape:

  • The EOD is -0.007. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.588. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.588. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.007MRQ-1.588+1.582
MRQ-1.588TTM-1.5880.000
TTM-1.588YOY-8.818+7.230
TTM-1.5885Y-10.071+8.483
5Y-10.07110Y-65.445+55.373
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.007-3.066+3.059
MRQ-1.588-3.181+1.593
TTM-1.588-3.515+1.927
YOY-8.818-4.590-4.228
5Y-10.071-8.121-1.950
10Y-65.445-9.163-56.282
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sorrento Therape is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -22.54 means the investor is paying $-22.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sorrento Therape:

  • The EOD is -0.094. Based on the equity, the company is expensive. -2
  • The MRQ is -22.541. Based on the equity, the company is expensive. -2
  • The TTM is -22.541. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.094MRQ-22.541+22.447
MRQ-22.541TTM-22.5410.000
TTM-22.541YOY32.811-55.351
TTM-22.5415Y20.053-42.594
5Y20.05310Y29.361-9.307
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0941.960-2.054
MRQ-22.5411.982-24.523
TTM-22.5412.197-24.738
YOY32.8112.400+30.411
5Y20.0533.585+16.468
10Y29.3614.229+25.132
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Sorrento Therape.

4.8.1. Institutions holding Sorrento Therape

Institutions are holding 0.039% of the shares of Sorrento Therape.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Lattice Capital Management LLC0.009405180000
2024-06-30Kitzinger Lautmann Capital Mgmt Inc0.005403000000
2024-06-30SlateStone Wealth, LLC0.003902143300
2024-06-30Huntington National Bank0.00090500100
2024-06-30AlphaMark Advisors, LLC0.00040213500
2024-06-30ARGI Investment Services, LLC000-12000-100
2024-06-30Federation des caisses Desjardins du Quebec000-7000-100
Total 0.020110369-19000-17.2%

4.9.2. Funds holding Sorrento Therape

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-08-31Belfund SICAV Belinvest Equity A USD Acc0.020.000911000000
2024-06-30AVIP BlackRock Advtg Small Cp Gr Prtfl0.00820.00034519600
2024-09-30BNYM Mellon SL Market Completion UC10.0038020675220.1065
2024-05-31Guggenheim Active Allocation Fund0.00060348100
2024-09-30BNYM Mellon AFLCIO SL Brd Mkt Index Inst0.00030192200
2024-09-30BNYM Mellon NSL Smid Cap Stck Index Inst0.00030189600
2024-09-30BNYM Mellon DB NSL Small Cap Stock Index0.000301700-66-3.7373
2024-06-30ZWJ Equity0.0001080000
2024-09-30BNYM Mellon NSL Mkt Completion Fund Inst0.00010765-8-1.0349
2024-09-30BNYM Mellon NSL Broad Market SIF Instl00400
Total 0.03370.0012186439-520.0%

5.3. Insider Transactions

Insiders are holding 0.89% of the shares of Sorrento Therape.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-25Henry JiBUY222222.06
2022-06-14Henry JiBUY100001.4
2021-12-27Kim JandaSELL30005.88
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Total Stockholder Equity 209,472-130,88478,58886,563165,151-86,40378,748-97,353-18,605



5.2. Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets472,840
Total Liabilities494,509
Total Stockholder Equity-18,605
 As reported
Total Liabilities 494,509
Total Stockholder Equity+ -18,605
Total Assets = 472,840

Assets

Total Assets472,840
Total Current Assets96,373
Long-term Assets376,467
Total Current Assets
Cash And Cash Equivalents 23,634
Short-term Investments 26,344
Net Receivables 24,469
Inventory 9,976
Other Current Assets 3,143
Total Current Assets  (as reported)96,373
Total Current Assets  (calculated)87,566
+/- 8,807
Long-term Assets
Property Plant Equipment 138,435
Goodwill 80,269
Long Term Investments 17,176
Intangible Assets 136,902
Long-term Assets  (as reported)376,467
Long-term Assets  (calculated)372,782
+/- 3,685

Liabilities & Shareholders' Equity

Total Current Liabilities327,922
Long-term Liabilities166,587
Total Stockholder Equity-18,605
Total Current Liabilities
Short-term Debt 30,166
Short Long Term Debt 16,286
Accounts payable 47,515
Other Current Liabilities 249,589
Total Current Liabilities  (as reported)327,922
Total Current Liabilities  (calculated)343,556
+/- 15,634
Long-term Liabilities
Long term Debt Total 19,130
Capital Lease Obligations 99,088
Deferred Long Term Liability 891
Long-term Liabilities  (as reported)166,587
Long-term Liabilities  (calculated)119,109
+/- 47,478
Total Stockholder Equity
Common Stock52
Retained Earnings -1,959,447
Accumulated Other Comprehensive Income 1,501
Capital Surplus 1,988,753
Treasury Stock-49,464
Total Stockholder Equity (as reported)-18,605
Total Stockholder Equity (calculated)-18,605
+/-0
Other
Capital Stock52
Cash and Short Term Investments 49,978
Common Stock Shares Outstanding 419,315
Common Stock Total Equity52
Current Deferred Revenue652
Liabilities and Stockholders Equity 472,840
Net Debt 110,870
Net Invested Capital 16,811
Net Tangible Assets -235,776
Net Working Capital -231,549
Minority Interest -3,064
Property Plant and Equipment Gross 189,855
Short Long Term Debt Total 134,504



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
> Total Assets 
0
0
0
0
22
395
3,554
5,688
4,569
6,782
92,582
141,541
343,519
401,586
431,613
624,087
557,632
535,822
694,818
472,840
472,840694,818535,822557,632624,087431,613401,586343,519141,54192,5826,7824,5695,6883,554395220000
   > Total Current Assets 
0
0
0
0
22
395
3,458
5,553
3,558
5,252
32,632
73,915
141,018
89,654
29,700
179,564
67,588
86,234
172,989
96,373
96,373172,98986,23467,588179,56429,70089,654141,01873,91532,6325,2523,5585,5533,458395220000
       Cash And Cash Equivalents 
0
0
0
0
22
380
3,430
5,278
3,467
5,091
31,667
71,902
39,038
82,398
20,429
158,738
22,521
56,464
36,665
23,634
23,63436,66556,46422,521158,73820,42982,39839,03871,90231,6675,0913,4675,2783,430380220000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
97,366
1,106
441
297
0
256,397
90,217
26,344
26,34490,217256,39702974411,10697,366000000000000
       Net Receivables 
0
0
0
0
0
0
0
246
61
80
394
732
2,618
2,985
3,926
4,359
14,513
15,506
18,715
24,469
24,46918,71515,50614,5134,3593,9262,9852,61873239480612460000000
       Other Current Assets 
0
0
0
0
0
14
28
30
30
81
571
1,281
1,996
3,165
4,904
16,170
27,192
3,721
7,482
3,143
3,1437,4823,72127,19216,1704,9043,1651,9961,281571813030281400000
   > Long-term Assets 
0
0
0
0
0
0
96
134
1,011
1,530
59,950
67,626
202,501
311,932
401,913
444,523
490,044
449,588
521,829
376,467
376,467521,829449,588490,044444,523401,913311,932202,50167,62659,9501,5301,01113496000000
       Property Plant Equipment 
0
0
0
0
0
0
73
96
988
1,481
2,440
2,277
7,246
12,707
19,345
24,384
76,272
73,913
126,498
138,435
138,435126,49873,91376,27224,38419,34512,7077,2462,2772,4401,4819889673000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
24,041
24,041
20,626
41,548
38,298
38,298
38,298
43,554
79,525
80,269
80,26979,52543,55438,29838,29838,29841,54820,62624,04124,0410000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
10,000
170,127
189,002
270,007
27,980
25,233
256,397
51,271
17,176
17,17651,271256,39725,23327,980270,007189,002170,12710,00000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
33,321
30,976
3,912
64,766
71,013
66,283
63,308
73,675
259,705
136,902
136,902259,70573,67563,30866,28371,01364,7663,91230,97633,3210000000000
       Other Assets 
0
0
0
0
0
0
23
38
23
49
148
332
590
3,909
3,250
50,570
49,925
300,498
1,216,647
0
01,216,647300,49849,92550,5703,2503,90959033214849233823000000
> Total Liabilities 
340
341
33
340
3
2
353
604
359
584
25,773
32,828
202,581
315,084
225,003
416,587
524,876
395,091
616,689
494,509
494,509616,689395,091524,876416,587225,003315,084202,58132,82825,7735843596043532334033341340
   > Total Current Liabilities 
340
341
33
340
3
2
353
604
359
584
5,480
9,557
30,873
76,085
78,955
61,621
115,206
96,480
139,453
327,922
327,922139,45396,480115,20661,62178,95576,08530,8739,5575,4805843596043532334033341340
       Short-term Debt 
10
10
0
10
0
0
0
0
0
0
374
3,316
4,835
209
5,211
10,150
39,583
26,834
43,519
30,166
30,16643,51926,83439,58310,1505,2112094,8353,3163740000001001010
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
3,316
4,835
209
5,211
10,150
36,261
23,208
31,980
16,286
16,28631,98023,20836,26110,1505,2112094,8353,31600000000000
       Accounts payable 
84
84
33
84
3
2
316
182
225
440
2,154
1,656
1,339
8,282
9,911
13,817
27,630
24,706
27,414
47,515
47,51527,41424,70627,63013,8179,9118,2821,3391,6562,1544402251823162384338484
       Other Current Liabilities 
246
247
0
246
0
0
37
222
135
145
2,952
3,486
-86,201
57,928
65,180
34,951
44,350
40,455
67,412
249,589
249,58967,41240,45544,35034,95165,18057,928-86,2013,4862,95214513522237002460247246
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
20,293
23,271
171,708
238,999
146,048
354,966
409,670
298,611
477,236
166,587
166,587477,236298,611409,670354,966146,048238,999171,70823,27120,2930000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
4,431
8,830
4,394
47,107
5,211
223,136
199,088
92,258
110,627
19,130
19,130110,62792,258199,088223,1365,21147,1074,3948,8304,4310000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
1,614
1,895
167,314
191,892
140,837
131,830
158,471
156,052
283,178
0
0283,178156,052158,471131,830140,837191,892167,3141,8951,6140000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
15,826
13,342
167,314
191,892
140,837
15,556
44,043
42,318
38,126
891
89138,12642,31844,04315,556140,837191,892167,31413,34215,8260000000000
> Total Stockholder Equity
-340
-341
-33
-340
19
392
3,201
5,084
4,209
6,197
66,809
108,713
145,152
80,037
199,568
209,472
78,588
165,151
78,748
-18,605
-18,60578,748165,15178,588209,472199,56880,037145,152108,71366,8096,1974,2095,0843,20139219-340-33-341-340
   Common Stock
14
14
14
14
8
1
23
25
26
30
2
4
4
6
9
13
18
28
32
52
523228181396442302625231814141414
   Retained Earnings -1,959,447-1,386,604-958,279-659,818-367,750-165,120-174,252-113,329-67,518-32,862-10,950-6,105-2,869-1,060-1,663-1,474-1,071-764-1,072-1,071
   Capital Surplus 
0
0
0
0
0
0
0
0
10,288
17,118
99,668
176,227
184,898
303,865
413,901
626,658
788,122
1,172,346
1,513,758
1,988,753
1,988,7531,513,7581,172,346788,122626,658413,901303,865184,898176,22799,66817,11810,28800000000
   Treasury Stock-49,464-49,464-49,464-49,464-49,464-49,464-49,464-140,938000000000000
   Other Stockholders Equity 
717
717
717
717
1,484
2,054
4,238
7,927
10,474
17,596
100,601
177,914
184,898
254,401
364,437
577,194
738,658
1,122,882
1,464,294
1,939,289
1,939,2891,464,2941,122,882738,658577,194364,437254,401184,898177,914100,60117,59610,4747,9274,2382,0541,484717717717717



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2022-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue62,839
Cost of Revenue-33,452
Gross Profit29,38729,387
 
Operating Income (+$)
Gross Profit29,387
Operating Expense-407,888
Operating Income-378,501-378,501
 
Operating Expense (+$)
Research Development221,226
Selling General Administrative182,337
Selling And Marketing Expenses0
Operating Expense407,888403,563
 
Net Interest Income (+$)
Interest Income0
Interest Expense-8,574
Other Finance Cost-0
Net Interest Income-8,574
 
Pretax Income (+$)
Operating Income-378,501
Net Interest Income-8,574
Other Non-Operating Income Expenses-67,284
Income Before Tax (EBT)-561,747-195,255
EBIT - interestExpense = -390,569
-561,747
-550,757
Interest Expense8,574
Earnings Before Interest and Taxes (EBIT)-381,995-553,173
Earnings Before Interest and Taxes (EBITDA)-364,520
 
After tax Income (+$)
Income Before Tax-561,747
Tax Provision--2,416
Net Income From Continuing Ops-559,331-559,331
Net Income-559,331
Net Income Applicable To Common Shares-572,843
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring188,942
Other Operating Expenses441,340
Total Other Income/Expenses Net-183,24675,858
 

Technical Analysis of Sorrento Therape
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sorrento Therape. The general trend of Sorrento Therape is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sorrento Therape's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sorrento Therape.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.008 < 0.01 < 0.01.

The bearish price targets are: 0.0006 > 0.0006 > 0.0006.

Tweet this
Sorrento Therape Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sorrento Therape. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sorrento Therape Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sorrento Therape. The current macd is 0.000089.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sorrento Therape price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sorrento Therape. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sorrento Therape price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Sorrento Therape Daily Moving Average Convergence/Divergence (MACD) ChartSorrento Therape Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sorrento Therape. The current adx is 18.02.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sorrento Therape shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Sorrento Therape Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sorrento Therape. The current sar is 0.000788.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sorrento Therape Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sorrento Therape. The current rsi is 48.94. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Sorrento Therape Daily Relative Strength Index (RSI) ChartSorrento Therape Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sorrento Therape. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sorrento Therape price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Sorrento Therape Daily Stochastic Oscillator ChartSorrento Therape Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sorrento Therape. The current cci is 178.68.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Sorrento Therape Daily Commodity Channel Index (CCI) ChartSorrento Therape Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sorrento Therape. The current cmo is -2.80945709.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Sorrento Therape Daily Chande Momentum Oscillator (CMO) ChartSorrento Therape Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sorrento Therape. The current willr is -67.0212766.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sorrento Therape is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sorrento Therape Daily Williams %R ChartSorrento Therape Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sorrento Therape.

Sorrento Therape Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sorrento Therape. The current atr is 0.00368614.

Sorrento Therape Daily Average True Range (ATR) ChartSorrento Therape Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sorrento Therape. The current obv is -321,599,224.

Sorrento Therape Daily On-Balance Volume (OBV) ChartSorrento Therape Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sorrento Therape. The current mfi is 58.33.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sorrento Therape Daily Money Flow Index (MFI) ChartSorrento Therape Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sorrento Therape.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Sorrento Therape Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sorrento Therape based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.939
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.007
OpenGreater thanClose0.003
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sorrento Therape with someone you think should read this too:
  • Are you bullish or bearish on Sorrento Therape? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sorrento Therape? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sorrento Therape

I send you an email if I find something interesting about Sorrento Therape.


Comments

How you think about this?

Leave a comment

Stay informed about Sorrento Therape.

Receive notifications about Sorrento Therape in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.